Mycophenolate Mofetil

Category API

Details	Specifications
CAS Number	128794-94-5
Molecular Formula	C23H31NO7
Molecular Weight	433.50 g/mol.
Synonyms	2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
Chemical Name	2-morpholin-4-ylethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate.
Common name	Mycophenolate Mofetil
Therapeutic use	Mycophenolate mofetil (MMF) is an immunosuppressant medication used primarily to prevent organ rejection in kidney, heart, or liver transplants by reducing the body's immune response.
Background	Mycophenolate mofetil is an immunosuppressant combined with drugs such as [Cyclosporine](https://go.drugbank.com/drugs/DB00091) and corticosteroids to prevent organ rejection after hepatic, renal, and cardiac transplants. It is marketed by Roche Pharmaceuticals and was granted FDA approval for the prophylaxis of transplant rejection in 1995. In addition to the above uses, mycophenolate mofetil has also been studied for the treatment of nephritis and other complications of autoimmune diseases.
Grade	EP & USP
Polymorph	Form-A
GTI	Risk assessment report available
Nitrosamines	Risk assessment report available
DMF Availability	-
Manufacturing batch size	374 Kg
Production capacity	Annual capacity is 20 – 24 tonnes
Stability data	Available

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Mycophenolate Mofetil are also Available for

Questions & Answers

FAQ on Mycophenolate Mofetil

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.